148 related articles for article (PubMed ID: 38060973)
1. Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.
Zhao Z; Patel PA; Slatnick L; Sitthi-Amorn A; Bielamowicz KJ; Nunez FA; Walsh AM; Hess J; Rossoff J; Elgarten C; Myers R; Saab R; Basbous M; Mccormick M; Aftandilian C; Richards R; Nessle CN; Tribble AC; Sheth Bhutada JK; Coven SL; Runco D; Wilkes J; Gurunathan A; Guinipero T; Belsky JA; Lee K; Wong V; Malhotra M; Armstrong A; Jerkins LP; Cross SJ; Fisher L; Stein MT; Wu NL; Yi T; Orgel E; Haeusler GM; Wolf J; Demedis JM; Miller TP; Esbenshade AJ
J Clin Oncol; 2024 Mar; 42(7):832-841. PubMed ID: 38060973
[TBL] [Abstract][Full Text] [Related]
2. Prospective Implementation of a Risk Prediction Model for Bloodstream Infection Safely Reduces Antibiotic Usage in Febrile Pediatric Cancer Patients Without Severe Neutropenia.
Esbenshade AJ; Zhao Z; Baird A; Holmes EA; Dulek DE; Banerjee R; Friedman DL
J Clin Oncol; 2020 Sep; 38(27):3150-3160. PubMed ID: 32762614
[TBL] [Abstract][Full Text] [Related]
3. Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia.
Esbenshade AJ; Zhao Z; Aftandilian C; Saab R; Wattier RL; Beauchemin M; Miller TP; Wilkes JJ; Kelly MJ; Fernbach A; Jeng M; Schwartz CL; Dvorak CC; Shyr Y; Moons KGM; Sulis ML; Friedman DL
Cancer; 2017 Oct; 123(19):3781-3790. PubMed ID: 28542918
[TBL] [Abstract][Full Text] [Related]
4. Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients.
Jackson K; Anderson V; Zhao Z; Kitko CL; Connelly JA; Ho RH; Banerjee R; Dulek DE; Friedman DL; Esbenshade AJ
Cancer; 2023 May; 129(10):1591-1601. PubMed ID: 36828805
[TBL] [Abstract][Full Text] [Related]
5. Non-neutropenic fever in children with cancer: Management, outcomes and clinical decision rule validation.
Walker H; Esbenshade AJ; Dale S; Bhatia K; Zhao Z; Babl FE; Conyers R; Haeusler GM
Pediatr Blood Cancer; 2022 Dec; 69(12):e29931. PubMed ID: 36031722
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer.
Esbenshade AJ; Pentima MC; Zhao Z; Shintani A; Esbenshade JC; Simpson ME; Montgomery KC; Lindell RB; Lee H; Wallace A; Garcia KL; Moons KG; Friedman DL
Pediatr Blood Cancer; 2015 Feb; 62(2):262-268. PubMed ID: 25327666
[TBL] [Abstract][Full Text] [Related]
7. Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.
Raad C; Behdenna A; Fuhrmann C; Conter C; Cuzzubbo D; Rasigade JP; Bertrand Y; Domenech C
Eur J Pediatr; 2021 Sep; 180(9):2921-2930. PubMed ID: 33835249
[TBL] [Abstract][Full Text] [Related]
8. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
[TBL] [Abstract][Full Text] [Related]
9. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
Alali M; Mayampurath A; Dai Y; Bartlett AH
Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
[TBL] [Abstract][Full Text] [Related]
10. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
11. Predictive Factors for Gram-negative Versus Gram-positive Bloodstream Infections in Children With Cancer.
Sfetsiori AE; Doganis D; Doudoulakakis A; Spyridis N; Pourtsidis A; Servitzoglou M; Nikita M; Papachristidou S; Magkou E; Dana H; Lebessi E; Kosmidis H; Baka M; Tsolia M
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e368-e373. PubMed ID: 34310469
[TBL] [Abstract][Full Text] [Related]
12. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
Joncour A; Puyade M; Michaud A; Tourani JM; Cazenave-Roblot F; Rammaert B
Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of bacterial bloodstream infections and association between neutropenia and 30-day mortality among oncology inpatients at a university hospital in Saudi Arabia.
Binkhamis K; Aldakhil I; Alhawas A; Alsaleh A; Albaroudi A; Almuhanna B; Makkawi M; Alzahrani M
Ann Saudi Med; 2023; 43(3):172-178. PubMed ID: 37270682
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of febrile, nonneutropenic pediatric oncology patients with central venous catheters who are not given empiric antibiotics.
Bartholomew F; Aftandilian C; Andrews J; Gutierrez K; Luna-Fineman S; Jeng M
J Pediatr; 2015 Jan; 166(1):157-62. PubMed ID: 25444524
[TBL] [Abstract][Full Text] [Related]
15. Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia.
Patel PA; DeGroote NP; Jackson K; Cash T; Castellino SM; Jaggi P; Esbenshade AJ; Miller TP
Cancer; 2022 Dec; 128(23):4129-4138. PubMed ID: 36238979
[TBL] [Abstract][Full Text] [Related]
16. Bacteremia in febrile nonneutropenic pediatric oncology patients.
Kelly MJ; Vivier PM; Panken TM; Schwartz CL
Pediatr Blood Cancer; 2010 Jan; 54(1):83-7. PubMed ID: 19774640
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory parameter dynamics as markers of blood stream infections in pediatric oncology patients with fever and neutropenia.
Hazan G; Ben-Shimol S; Fruchtman Y; Abu-Quider A; Kapelushnik J; Moser A; Falup-Pecurariu O; Greenberg D
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e275-9. PubMed ID: 24276046
[TBL] [Abstract][Full Text] [Related]
18. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
[TBL] [Abstract][Full Text] [Related]
19. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
Ali N; Adil SN; Shaikh MU
Transpl Infect Dis; 2014 Feb; 16(1):98-105. PubMed ID: 24383473
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for nosocomial primary bloodstream infection in pediatric intensive care unit patients: a 2-year prospective cohort study.
Elward AM; Fraser VJ
Infect Control Hosp Epidemiol; 2006 Jun; 27(6):553-60. PubMed ID: 16755473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
